Nanjing, China

Xiaojian Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: China Pharmaceutical University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaojian Wang. Retrieved from https://idiyas.com/inventor/xiaojian-wang-lx6fk0mr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaojian Wang: Innovator in Pharmaceutical Chemistry

Introduction

Xiaojian Wang is an esteemed inventor based in Nanjing, China, known for his contributions to pharmaceutical chemistry. With a focus on innovative solutions for medicinal applications, Wang has dedicated his career to advancing drug development.

Latest Patents

Wang holds one notable patent that relates to a garcinia derivative Formula (I) and its methods of preparation and medicinal use. This invention is a structurally simplified analogue of gambogic acid, a compound known for its anti-cancer properties. With the potential for use in preparing anti-tumor drugs, this invention opens new avenues in the field of cancer treatment.

Career Highlights

Xiaojian Wang is affiliated with China Pharmaceutical University, where he engages in cutting-edge research focused on the intersection of chemistry and medicine. His work demonstrates a commitment to enhancing therapeutic options for patients through innovative chemical formulations.

Collaborations

Wang collaborates with fellow researchers Qidong You and Qian Yang, contributing to a collaborative environment that fosters scientific discoveries and advancements in their respective fields.

Conclusion

Xiaojian Wang's contributions to pharmaceutical chemistry highlight the vital role of inventors in developing new medical treatments. Through his innovative patents and collaborative efforts, he continues to push the boundaries of science and improve healthcare possibilities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…